Product
PXS-4728
Aliases
PXS-4728 (A)
1 clinical trial
1 indication
Indication
REM Sleep Behavior DisorderClinical trial
A Phase 2a, Multi Centre, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Effect of 12 Weeks Treatment With Oral PXS-4728A on Microglia Activation, as Measured by Positron Emission Tomography, in Participants With Isolated Rapid Eye Movement Sleep Behavior DisorderStatus: Recruiting, Estimated PCD: 2024-09-30